-
Michael Quick
https://ncihub.cancer.gov/members/3874
-
Regulatory Challenges and Opportunities for Digital Pathology
29 Nov 2016 | | Contributor(s):: Nick Anderson
FDA has cleared or approved a number of digital pathology devices for different intended uses, such as digital read and image analysis of immunohistochemically stained tissue slides, classification and enumeration of peripheral blood cells, and initial screening of cervical cytology slides. ...
-
Anant Madabhushi
Dr. Anant Madabhushi is the Director of the Center for Computational Imaging and Personalized Diagnostics (CCIPD) and a Professor in the Departments of Biomedical Engineering, Pathology, Radiology,...
https://ncihub.cancer.gov/members/2676
-
Jeroen van der Laak
https://ncihub.cancer.gov/members/2071
-
Lewis A Hassell
Director of Anatomic Pathology, Univ. of Oklahoma HSCPractice focused on GI, Bone and Gyn pathology, management, and cytopathologyLong term interest in developing diagnostic capacity in...
https://ncihub.cancer.gov/members/1747
-
Tyna Hope
https://ncihub.cancer.gov/members/1703
-
Remy Tumbar
https://ncihub.cancer.gov/members/1597
-
Amanda J Lowe
https://ncihub.cancer.gov/members/1573
-
MARIOS GAVRIELIDES
Marios A. Gavrielides received B.S. and M.S. degrees in Electrical Engineering from the University of South Florida, in 1994 and 1996 respectively, and a Ph.D. degree in Biomedical Engineering from...
https://ncihub.cancer.gov/members/1558